QA: Endonovo Therapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001528172_2018_Endonovo_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001528172, Endonovo Therapeutics INC

  xvar xval
0 AssetsCurrent 111,173
1 IntangibleAssetsNetIncludingGoodwill 4,500,000
2 PropertyPlantAndEquipmentNet 1,064
3 remainder_Assets 0
4 LiabilitiesCurrent 0
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 14,162,537
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 4,603,886
11 remainder_Revenues 0
12 remainder_NetIncome -6,206,274
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,612,237
1 Liabilities 14,162,537
2 Expenses 4,603,886
3 Revenues 0
4 StockholdersEquity -9,550,300
5 NetIncome -10,810,160
6 ComprehensiveNetIncome -10,810,160
7 BaseVar 14,792,467
8 EconomicCapitalRatiobeforeLimitedLiability -3.37
9 EconomicCapitalRatio 0.569

Edgar->Model Mapping

Feature Distribution